LINC00470: A Long Intergenic Non-Protein-Coding RNA (G56651)

Target Name: LINC00470

NCBI ID: G56651

LINC00470

Other Name(s): long intergenic non-protein coding RNA 470 | C18orf2 | Long intergenic non-protein coding RNA 470, transcript variant 1

LINC00470: A Long Intergenic Non-Protein-Coding RNA

LINC00470 is a long intergenic non-protein-coding RNA (lncRNA) that has been identified in various studies as a potential drug target or biomarker. It is a non-coding RNA molecule that is expressed in a variety of tissues and cells, including brain, heart, and peripheral blood cells. LINC00470 has been shown to play a role in the regulation of cellular processes, including cell adhesion, migration, and survival.

Drug Target Potential

LINC00470 has been identified as a potential drug target due to its unique structure and the various functions it is known to play in the cell. One of the key features of LINC00470 is its ability to interact with various protein molecules, including the protein known as PDGF-BB. This interaction suggests that LINC00470 could be a useful target for drugs that are designed to inhibit the activity of PDGF-BB.

In addition to its interaction with PDGF-BB, LINC00470 has also been shown to interact with other proteins that are involved in cell signaling pathways, including the protein known as NF-kappa-B. This interaction suggests that LINC00470 may be a useful target for drugs that are designed to inhibit the activity of NF-kappa-B.

Biomarker Potential

LINC00470 has also been identified as a potential biomarker for a variety of diseases, including cancer. This is because the expression of LINC00470 has been shown to be regulated in a variety of tissues and diseases, including cancer. For example, studies have shown that LINC00470 is downregulated in various types of cancer, and that inhibition of LINC00470 has been shown to enhance the sensitivity of cancer cells to chemotherapy.

Another potential use of LINC00470 as a biomarker is its ability to be expressed and detected in a variety of tissues and cells, including cancer cells. This makes LINC00470 a potentially useful biomarker for the diagnosis and treatment of cancer.

Methods

To study the potential drug target and biomarker properties of LINC00470, researchers have used a variety of techniques, including RNA sequencing, qRT-PCR, and western blotting. These studies have shown that LINC00470 is expressed in a variety of tissues and cells, including brain, heart, and peripheral blood cells. They have also shown that LINC00470 interacts with PDGF-BB, NF-kappa-B, and other proteins involved in cell signaling pathways.

Conclusion

LINC00470 is a long intergenic non-protein-coding RNA that has been identified as a potential drug target and biomarker. Its unique structure and interactions with various proteins have led to its potential as a target for drugs that are designed to inhibit the activity of PDGF-BB and other proteins involved in cell signaling pathways. Further research is needed to determine the full extent of LINC00470's potential as a drug target and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 470

The "LINC00470 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00470 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets